Saloua Takhlidjt
Rouen, 76000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Whole body distribution of the regulatory peptide 26RFa in male and female mice.
Journal: Peptides
Published: March 21, 2025
Glucose and energy metabolism are impaired in mice deficient for orexins.
Journal: The Journal of endocrinology
Published: November 20, 2024
Serum levels of the incretin-like peptide 26RFa are diminished in women living with obesity and diabetes and restored after sleeve gastrectomy: Results from the prospective pilot RFa-Ba-S study.
Journal: Diabetes, obesity & metabolism
Published: May 13, 2024
Long-Term Dynamics of Serum α-MSH and α-MSH-Binding Immunoglobulins with a Link to Gut Microbiota Composition in Patients with Anorexia Nervosa.
Journal: Neuroendocrinology
Published: March 11, 2024
The 26RFa (QRFP)/GPR103 Neuropeptidergic System: A Key Regulator of Energy and Glucose Metabolism.
Journal: Neuroendocrinology
Published: November 30, 2023
Immunoglobulin G is a natural oxytocin carrier which modulates oxytocin receptor signaling: relevance to aggressive behavior in humans.
Journal: Discover mental health
Published: September 05, 2023
The 26RFa (QRFP)/GPR103 neuropeptidergic system in mice relays insulin signalling into the brain to regulate glucose homeostasis.
Journal: Diabetologia
Published: January 07, 2022
Acute but Not Chronic Central Administration of the Neuropeptide 26RFa (QRFP) Improves Glucose Homeostasis in Obese/Diabetic Mice.
Journal: Neuroendocrinology
Published: September 30, 2021
Glucose homeostasis is impaired in mice deficient in the neuropeptide 26RFa (QRFP).
Journal: BMJ open diabetes research & care
Published: October 09, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026